Intellia (NTLA) director awarded RSUs and stock options in new grant
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Intellia Therapeutics director William J. Chase received new equity awards. On June 9, he was granted 9,200 restricted stock units, each representing the right to receive one share of Intellia common stock upon vesting.
He also received a stock option covering 13,300 shares of common stock at an exercise price of $12.89 per share. This option vests in full on the earlier of the first anniversary of the grant date or the next annual stockholders’ meeting. After the RSU grant, Chase directly holds 143,893 common shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
CHASE WILLIAM J
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 13,300 | $0.00 | -- |
| Grant/Award | Common Stock | 9,200 | $0.00 | -- |
Holdings After Transaction:
Stock Option (right to buy) — 13,300 shares (Direct, null);
Common Stock — 143,893 shares (Direct, null)
Footnotes (1)
- Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit. This option was granted on June 9, 2026 with respect to 13,300 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant.
Key Figures
RSUs granted: 9,200 units
Option shares granted: 13,300 shares
Option exercise price: $12.89 per share
+2 more
5 metrics
RSUs granted
9,200 units
Restricted stock units granted June 9, 2026
Option shares granted
13,300 shares
Stock option grant June 9, 2026
Option exercise price
$12.89 per share
Stock option on Intellia common stock
Shares held after grant
143,893 shares
Common stock directly owned after RSU award
Option expiration date
June 8, 2036
End of exercise period for granted option
Key Terms
restricted stock units, Stock Option (right to buy), exercise price, vests in full
4 terms
restricted stock units financial
"grant of restricted stock units representing a contingent right to receive one share"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Stock Option (right to buy) financial
"Stock Option (right to buy) with respect to 13,300 shares of Common Stock"
exercise price financial
"conversion or exercise price of 12.8900 per share for the stock option"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vests in full financial
"vests in full on the earlier to occur of the first anniversary or next annual meeting"
FAQ
What did Intellia Therapeutics (NTLA) director William J. Chase receive in this Form 4?
He received equity compensation consisting of restricted stock units and stock options. The grant includes 9,200 RSUs and an option on 13,300 shares, providing additional long-term alignment with Intellia’s common stock performance.
How many restricted stock units were granted to the NTLA director?
William J. Chase was granted 9,200 restricted stock units. Each RSU represents a contingent right to receive one share of Intellia common stock, typically delivered when vesting conditions specified in the award agreement are met.
What are the key terms of the stock options granted to the NTLA director?
He received a stock option for 13,300 shares of Intellia common stock at an exercise price of $12.89 per share. The option vests fully on the earlier of the first anniversary of June 9, 2026, or the next annual stockholders’ meeting.
When do William J. Chase’s new Intellia stock options expire?
The stock options granted to William J. Chase expire on June 8, 2036. This long-dated expiration gives him a multi-year window to decide whether to exercise the options, depending on Intellia’s stock performance and his personal circumstances.